Several studies reveal that all COVID vaccinations cause discomfort and edoema at the injection site. A senior  interventional cardiologist Dr. Adil Barakat Al Riyami stated there has been no reputable study demonstrating a spike in heart attacks post-vaccinations in Oman or globally.

Post-vaccination myocarditis has been observed globally, including in Oman.Myocarditis seldom causes long-term consequences. Myocarditis produces the production of troponin, the same enzyme produced in heart attack victims.

Al Riyami highlighted that in one of the important studies in this context, 54 cases of myocarditis were documented throughout more than 2.5 million COVID vaccination recipients, or 2.13 cases per 100,000 persons.

“That’s the same frequency of myocarditis even without immunizations,” he said. 76% of occurrences were mild, 22% serious, and 1 was critical.

Al Riyami questioned persons who asked the OHA’s social media accounts about cardiac arrest-related fatalities in Oman. We haven’t seen more heart attacks in vaccinated persons, he added.

The OHA also issued cautions in this respect, stating: “In a recently published research, the influenza vaccination, when supplied to heart patients, lowered the death rate by 41% and the occurrence of another stroke by 14%, less than a year after follow-up since such vaccine was initially given.

Myocarditis causes joint discomfort, headaches, body pains, fever, sore throat, diarrhoea, palpitions in the heart, along with a shortness of breath during the rest period following some exertion.

Dr. Zaid Al Hinai, of the paediatric communicable diseases from Sultan Qaboos University, observed an increase in cardiac difficulties in some Omanis who recovered from COVID-19. Hear Stroke at disease rates and strokes have risen in society and among doctors, he noted. These incidents raise questions about why they’re happening more often.

“Scientific data we have indicates to an upsurge in cardiovascular problems after major rounds of COVID-19 viral infections,” he noted. The good thing is that most individuals who recover from COVID-19 won’t develop these consequences, and immunizations continue to offer protection.

Al Hinai cited studies from different universities that tried to map the association between cardiac problems and COVID-19.

In February, ‘Nature Medicine’ released one of the best studies on this topic. In this study, researchers in the US monitored more than 150,000 COVID-19 patients for a year after they recovered.

Al Hinai said that despite recovering, these persons had a higher risk of cardiovascular issues and strokes. They observed that 45 out of 1,000 COVID survivors had cardiovascular or thrombotic problems after recovery, which is much higher than normal.

The study’s authors suggested that health systems must be ready for greater cardiovascular illnesses after COVID-19 infection waves. They emphasised early cardiac disease identification among COVID-19 survivors.

Some may say COVID vaccinations cause cardiac issues, however Zaid Al Hinai refuted this.

Again, the question is the involvement of immunizations in this issue,” he added. “While some have sought to blame these issues on vaccines, the fact would be that the immunizations have really safeguarded against these cardiac abnormalities.”

Al Hinai cited a Western Reserve University research to confirm greater cardiac issues among COVID-19 survivors. The research examined 25,000 vaccinated, infected, and recovered patients.

They observed that three months after infection, these individuals had a reduced risk of cardiovascular disease and mortality than unvaccinated COVID-19 patients. This study and others found that immunization decreased COVID-19’s acute and long-term consequences.

Al Hinai ends by saying that according to available scientific data, there appears to be an upsurge in cardio issues post infections from COVID-19. But, for most patients who go on to recover, these cardiovascular problems do not pose a risk. The coronavirus immunizations have given patients a blanket of protection. 

Leave a Reply

Your email address will not be published.